These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15803142)

  • 1. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
    Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
    Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
    Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
    Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
    Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
    Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
    Chen Y; Chen XY
    Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.
    You X; Yang YC; Ke X; Hong SL; Hu GH
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):251-8. PubMed ID: 24323909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
    Mei YP; Zhu XF; Zhou JM; Huang H; Deng R; Zeng YX
    Cancer Lett; 2006 Feb; 232(2):189-98. PubMed ID: 16458115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
    Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
    Li G; Li XP; Peng Y; Liu X; Li XH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.
    Yang L; Lu Z; Ma X; Cao Y; Sun LQ
    Molecules; 2010 Sep; 15(9):6127-39. PubMed ID: 20877211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
    Huang H; Huang PC
    Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.
    Yu JS; Tsai HC; Wu CC; Weng LP; Li HP; Chung PJ; Chang YS
    Oncogene; 2002 Nov; 21(52):8047-61. PubMed ID: 12439755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.
    Piché A; Kasono K; Johanning F; Curiel TJ; Curiel DT
    Gene Ther; 1998 Sep; 5(9):1171-9. PubMed ID: 9930317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells].
    Zhao JM; Li MY; Yang Z; Li Z; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):638-42. PubMed ID: 15958297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation.
    Kawanishi M
    Virology; 1997 Feb; 228(2):244-50. PubMed ID: 9123831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P; Loomis R; Carbone R; Srimatkandada S; Lacy J
    Eur J Haematol; 2008 May; 80(5):407-18. PubMed ID: 18221384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.